Journal of Dermatology Research and Skin Care

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Dermatology Research and Skin Care (2023) Volume 7, Issue 6

A comprehensive exploration on mysteries of appendageal tumors.

Fatimah Alruwaii*

Departments of Dermatology, University of California, San Diego, California, US

*Corresponding Author:
Fatimah Alruwaii
Department of Dermatology
University of California, San Diego, California

Received:25-Nov-2023,Manuscript No. AADRSC-23-122501; Editor assigned: 27-Nov-2023, PreQC No. AADRSC-23-122501 (PQ); Reviewed:11-Dec-2023, QC No. AADRSC-23-122501; Revised:16-Dec-2023, Manuscript No. AADRSC-23-122501 (R); Published:23 -Dec-2023, DOI: 10.35841/aadrsc- 7.5.184

Citation: Alruwaii F. A comprehensive exploration on mysteries of appendageal tumors. Dermatol Res Skin Care. 2023; 7(6):184

Visit for more related articles at Journal of Dermatology Research and Skin Care


Appendageal tumors, a diverse group of neoplasms arising from skin appendages, represent a fascinating yet intricate facet of dermatopathology. These tumors encompass a wide array of histological subtypes, each presenting unique challenges in diagnosis and management. This article delves into the intricacies of appendageal tumors, shedding light on their classification, clinical manifestations, diagnostic approaches, and current therapeutic strategies. Appendageal tumors originate from various skin appendages, including hair follicles, sebaceous glands, sweat glands, and nails. These tumors are broadly classified into adnexal tumors and appendageal tumors. Adnexal tumors include pilomatricoma, trichoepithelioma, and trichofolliculoma, among others. Appendageal tumors encompass both adnexal and sweat gland neoplasms [1].

Adnexal tumors

Pilomatricoma: A benign skin appendageal tumor arising from hair follicle matrix cells, pilomatricomas often present as firm, mobile nodules, primarily affecting the head and neck. Histologically, these tumors exhibit characteristic ghost cells and basaloid cells. Trichoepithelioma: This benign tumor originates from the hair follicle's outer root sheath and typically manifests as small, skin-colored papules or nodules. Histopathologically, trichoepitheliomas are characterized by nests of basaloid cells with peripheral palisading [2].

Trichofolliculoma: Arising from the infundibulum of the hair follicle, trichofolliculomas are characterized by dilated hair follicles filled with keratinous material. These tumors often present as solitary papules on the face. Sweat gland tumors Eccrine spiradenoma: Originating from the eccrine sweat glands, eccrine spiradenomas are typically located on the trunk and extremities. These benign tumors are histologically characterized by a dual population of cells with a myoepithelial component [3].


Cylindromas arise from the apocrine sweat glands and often present as multiple nodules on the head and neck. Histologically, cylindromas exhibit nests of basaloid cells arranged in a characteristic jigsaw puzzle-like pattern. Clinical manifestations : The clinical presentation of appendageal tumors varies widely, contributing to the diagnostic challenges associated with these neoplasms. While some tumors may be asymptomatic, others can cause pain, itching, or cosmetic concerns. Furthermore, the location of these tumors on the body often influences their clinical manifestations [4].

Head and neck tumors: Adnexal tumors such as trichoepitheliomas and pilomatricomas are frequently encountered on the face and neck, presenting as small, flesh colored nodules. Cylindromas, originating from apocrine sweat glands, commonly manifest as multiple nodules on the scalp and forehead [5].

Trunk and extremity tumors: Eccrine spiradenomas are often found on the trunk and extremities, presenting as solitary, painful nodules. Trichofolliculomas, arising from hair follicles, may appear as solitary papules on the trunk or extremities. Diagnosis and differential diagnosis The diagnosis of appendageal tumors relies on a combination of clinical, histopathological, and sometimes immunohistochemical assessments. Dermatologists and pathologists play pivotal roles in accurately identifying these tumors, given their diverse presentations [6].

Clinical assessment: Thorough clinical examination, including the tumor's location, size, color, and associated symptoms, provides essential clues for diagnosis. Histopathological evaluation: Biopsy specimens are crucial for histopathological assessment. The characteristic features of each tumor subtype aid in accurate diagnosis. Immunohistochemistry: In challenging cases, immunohistochemical stains may be employed to differentiate between various tumor types. For instance, cytokeratin markers can help distinguish between adnexal and sweat gland tumors [7].

Differential diagnosis: Given the diverse nature of appendageal tumors, the differential diagnosis includes a range of skin neoplasms. Dermatofibromas, basal cell carcinomas, and sebaceous hyperplasia are among the entities that must be considered. Management and treatment strategies The management of appendageal tumors is primarily surgical, with complete excision being the preferred approach for both benign and malignant variants. Additionally, careful consideration must be given to the tumor's location, size, and histological subtype when planning surgical interventions [8].

Benign tumors: Benign adnexal tumors, such as trichoepitheliomas and pilomatricomas, can often be managed with simple excision. The goal is complete removal while preserving cosmetic and functional integrity. For sweat gland tumors like eccrine spiradenomas, surgical excision is also the mainstay of treatment. However, careful attention to the potential infiltrative nature of these tumors is crucial to minimize the risk of recurrence [9].

Malignant tumors: Malignant appendageal tumors, though rare, require a more comprehensive approach. Mohs micrographic surgery, with its meticulous tissue examination, is often employed to ensure complete removal while preserving surrounding healthy tissue. Adjuvant therapies, including radiation therapy and, in select cases, chemotherapy, may be considered for aggressive malignant tumors [10].


Appendageal tumors, with their diverse histopathological subtypes and clinical presentations, present a challenging landscape for dermatologists and pathologists. Accurate diagnosis and appropriate management are crucial to ensure optimal outcomes for patients. As our understanding of these tumors continues to evolve, on-going research and advancements in diagnostic techniques and treatment modalities hold the promise of improving the care and outcomes for individuals affected by appendageal tumors.


  1. Jensen P, Møller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 2000;42(2):307.
  2. Indexed at, Google Scholar, Cross Ref

  3. Chastain MA, Millikan LE. Pilomatrix dysplasia in an immunosuppressed patient. J Am Acad Dermatol. 2000;43(1):118-22.
  4. Indexed at, Google Scholar, Cross Ref

  5. Harwood CA, Swale VJ, Bataille VA, et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol. 2001;116(2):246-53.
  6. Indexed at, Google Scholar, Cross Ref

  7. Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol. 2001;117(4):852-7.
  8. Indexed at, Google Scholar, Cross Ref

  9. Hogan DJ. Allergic contact dermatitis to ethylenediamine. A continuing problem. Dermatol Clin. 1990;8(1):133-6.
  10. Indexed at, Google Scholar, Cross Ref

  11. Adachi J, Endo K, Fukuzumi T, et al. Increasing incidence of streptococcal impetigo in atopic dermatitis. J Dermatol Sci. 1998;17(1):45-53.
  12. Indexed at, Google Scholar, Cross Ref

  13. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: A requirement for allergen sensitization? J Invest Dermatol. 2012;132(3):949-63.
  14. Indexed at, Google Scholar, Cross Ref

  15. Peroni DG, Piacentini GL, Bodini A, et al. Prevalence and risk factors for atopic dermatitis in preschool children. Br J Dermatol. 2008;158(3):539-43.
  16. Indexed at, Google Scholar, Cross Ref

  17. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: A systematic review. Pediatr Dermatol. 2008;25(1):1-6.
  18. Indexed at, Google Scholar, Cross Ref

  19. HC W. The UK Working Party's Diagnostic Criteria for Atopic Dermatitis. Br J Dermatol. 1994;131:406-16.
  20. Indexed at, Google Scholar, Cross Ref

Get the App